Fintel on MSN22h
Evercore ISI Group Upgrades CRISPR Therapeutics (CRSP)Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback